Walvax Biotechnology Co., Ltd. (SHE:300142)
12.28
+0.22 (1.82%)
At close: Mar 16, 2026
3.45% (1Y)
| Market Cap | 19.64B +0.1% |
| Revenue (ttm) | 2.40B -22.5% |
| Net Income | 49.24M -59.8% |
| EPS | 0.03 -59.8% |
| Shares Out | 1.60B |
| PE Ratio | 398.82 |
| Forward PE | 75.57 |
| Dividend | 0.03 (0.24%) |
| Ex-Dividend Date | Jan 9, 2026 |
| Volume | 31,077,080 |
| Average Volume | 28,512,452 |
| Open | 12.18 |
| Previous Close | 12.06 |
| Day's Range | 12.12 - 12.33 |
| 52-Week Range | 9.70 - 14.65 |
| Beta | 0.56 |
| RSI | 54.07 |
| Earnings Date | Mar 28, 2026 |